CXCR2/CXCR1 dual antagonists (Merck & Co)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCXCR2/CXCR1 dual antagonists (Merck & Co)
Drug Alias NameCXCR2/CXCR1 dual antagonists (Schering-Plough)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 1 antagonistsC-X-C motif chemokine receptor 2 antagonists
TargetsC-X-C motif chemokine receptor 1C-X-C motif chemokine receptor 2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSchering-Plough Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSchering-Plough CorpMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A